Sandrine Tury

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.

M. Espié, M. Edelman, F. Reyal, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX

F. Lallemand, A. Vincent-Salomon, S. Vacher, 2018, BMC Biology.

The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers

F. Lallemand, S. Vacher, I. Bièche, 2018, The Journal of pathology.

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer

S. Vacher, I. Bièche, V. Bécette, 2016, Oncotarget.

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX

F. Lallemand, A. Vincent-Salomon, S. Vacher, 2018, BMC Biology.